Purchases and Sales Made in Q4 2023 in Sab Biotherapeutics Inc Wt Exp (SABSW)
This table provides information about the institutional ownership of Sab Biotherapeutics Inc Wt Exp (SABSW) during Q4 2023. The information is specifically focused on institutions that hold shares of SAB BIOTHERAPEUTICS INC WT EXP.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
29.1KNew |
$872 - $2.91K
|
29.1K
$872
|
|
|
Feb 01, 2024
Q4 2023
|
Wolverine Asset Management LLC
|
BUY
|
- |
10K+ 78.69% |
$301 - $1K
|
22.8K
$684
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
2.5K+ 1.71% |
$75 - $250
|
149K
$4.47K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Shaolin Capital Management LLC
Miami, FL |
SELL
|
- |
-94.1K- 20.2% |
$2.82K - $9.41K
|
372K
$11.1K
|